EWTX
Price
$27.95
Change
-$1.70 (-5.73%)
Updated
Feb 4, 02:40 PM (EDT)
Capitalization
3.14B
15 days until earnings call
Intraday BUY SELL Signals
OPORF
Price
$0.24
Change
-$0.05 (-17.24%)
Updated
Feb 14 closing price
Capitalization
56.37M
Intraday BUY SELL Signals
Interact to see
Advertisement

EWTX vs OPORF

Header iconEWTX vs OPORF Comparison
Open Charts EWTX vs OPORFBanner chart's image
Edgewise Therapeutics
Price$27.95
Change-$1.70 (-5.73%)
Volume$1.45K
Capitalization3.14B
OPEN ORPHAN
Price$0.24
Change-$0.05 (-17.24%)
Volume$3K
Capitalization56.37M
EWTX vs OPORF Comparison Chart in %
EWTX
Daily Signal:
Gain/Loss:
OPORF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EWTX vs. OPORF commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EWTX is a Buy and OPORF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (EWTX: $29.65 vs. OPORF: $0.09)
Brand notoriety: EWTX and OPORF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EWTX: 67% vs. OPORF: 13%
Market capitalization -- EWTX: $3.14B vs. OPORF: $56.37M
EWTX [@Biotechnology] is valued at $3.14B. OPORF’s [@Biotechnology] market capitalization is $56.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EWTX’s FA Score shows that 1 FA rating(s) are green whileOPORF’s FA Score has 2 green FA rating(s).

  • EWTX’s FA Score: 1 green, 4 red.
  • OPORF’s FA Score: 2 green, 3 red.
According to our system of comparison, both EWTX and OPORF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EWTX’s TA Score shows that 4 TA indicator(s) are bullish while OPORF’s TA Score has 0 bullish TA indicator(s).

  • EWTX’s TA Score: 4 bullish, 3 bearish.
  • OPORF’s TA Score: 0 bullish, 3 bearish.
According to our system of comparison, EWTX is a better buy in the short-term than OPORF.

Price Growth

EWTX (@Biotechnology) experienced а +0.99% price change this week, while OPORF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

EWTX is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EWTX($3.14B) has a higher market cap than OPORF($56.4M). EWTX YTD gains are higher at: 19.484 vs. OPORF (-64.125). OPORF has higher annual earnings (EBITDA): 14M vs. EWTX (-178.65M). OPORF has higher revenues than EWTX: OPORF (56M) vs EWTX (0).
EWTXOPORFEWTX / OPORF
Capitalization3.14B56.4M5,564%
EBITDA-178.65M14M-1,276%
Gain YTD19.484-64.125-30%
P/E RatioN/A8.18-
Revenue056M-
Total Cash563MN/A-
Total Debt4.18MN/A-
TECHNICAL ANALYSIS
Technical Analysis
EWTXOPORF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
12%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
30%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
25%
View a ticker or compare two or three
Interact to see
Advertisement
EWTX
Daily Signal:
Gain/Loss:
OPORF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCECX17.980.16
+0.90%
ClearBridge Emerging Markets C
CSGYX37.190.29
+0.79%
Columbia Small Cap Growth Inst3
WDIIX15.620.09
+0.58%
Wilmington Enhanced Div Inc Strat I
FEMSX27.01N/A
N/A
Fidelity Series Emerging Markets Opps
USCGX14.35-0.02
-0.14%
Victory Capital Growth

EWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EWTX has been loosely correlated with CGON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if EWTX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EWTX
1D Price
Change %
EWTX100%
+2.63%
CGON - EWTX
41%
Loosely correlated
-3.28%
BMRN - EWTX
38%
Loosely correlated
-0.59%
IMTX - EWTX
38%
Loosely correlated
-0.40%
BCYC - EWTX
38%
Loosely correlated
-7.55%
XNCR - EWTX
37%
Loosely correlated
-0.99%
More

OPORF and

Correlation & Price change

A.I.dvisor tells us that OPORF and ENTX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPORF and ENTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPORF
1D Price
Change %
OPORF100%
N/A
ENTX - OPORF
31%
Poorly correlated
-7.52%
PMN - OPORF
23%
Poorly correlated
+13.17%
EWTX - OPORF
6%
Poorly correlated
+2.63%
BCTX - OPORF
4%
Poorly correlated
-3.13%
GANX - OPORF
3%
Poorly correlated
+1.69%
More